About 1,010,000 results
Open links in new tab
  1. 340B Drug Pricing Program | HRSA

    The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. …

  2. 340B Eligibility | HRSA

    Discover eligibility and registration details for HRSA's 340B Drug Pricing Program to help entities access discounted medications

  3. 340B Educational Resources | HRSA

    Our website provides resources to help 340B Program stakeholders with navigating the 340B Program, including registration and implementation, requirements compliance, program …

  4. Program Requirements | HRSA

    To purchase drugs at the 340B price, covered entities must continue to meet the requirements of the 340B Drug Pricing Program.

  5. 340B Rebate Model Pilot Program | HRSA

    The 340B Rebate Model Pilot Program consists of a selected group of drugs of manufacturers who have submitted plans meeting specific criteria that HRSA has approved.

  6. 340B-Search Covered Entities

    An official website of the United States government Here's how you know About 340B OPAIS Home Search Reports

  7. 340B Program Regulations | HRSA

    May 1, 2017 · 340B Drug Pricing Program; Administrative Dispute Resolution Regulation (PDF - 354 KB) 6/18/2024Ceiling Price and Manufacturer Civil Monetary Penalties Final Rule; …

  8. 340B Office of Pharmacy Affairs Information System | HRSA

    The 340B registration and pricing databases are known as the 340B Office of Pharmacy Affairs Information System (340B OPAIS). Authorized users of 340B OPAIS must have a user …

  9. Ceiling Price Lookup

    In order to calculate the 340B ceiling price, the Unit Rebate Amount (URA) is subtracted from the Average Manufacturer Price (AMP) for the smallest unit of measure [340B Ceiling Price = …

  10. Contract Pharmacy Services | HRSA

    A contract pharmacy must register for the 340B Program and ensure compliance with all 340B Program requirements before giving out 340B drugs for a covered entity.